Cosentyx unoready 300 MG pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FTGUS
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,387
Award facts
- Contract value 100% obligated
- $25,387.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,387.00 to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors in 2 ml formulations. This non-set-aside, firm fixed-price delivery order was awarded on July 30, 2025, with an ultimate completion date of July 31, 2025. The contractor will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive $999.999 billion pharmaceutical supply vehicle running through December 2026 that enables the company to supply medications and medical commodities to support military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, has demonstrated capability to meet competitive federal procurement requirements through its extensive portfolio of delivery orders with the Defense Logistics Agency covering a wide spectrum of pharmaceutical products and medical supplies. As a prime contractor under the DLA Troop Support Medical IDC, the company serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Cosentyx delivery supports military medical supply needs for this immunosuppressive biologic medication commonly used to treat autoimmune conditions, furthering the Defense Logistics Agency's mission to provision the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FTGUS?
SPE2DB25FTGUS was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 30, 2025.
How much is contract SPE2DB25FTGUS worth?
The government has obligated $25,387 on SPE2DB25FTGUS.
Is contract SPE2DB25FTGUS an order under another contract?
Yes. SPE2DB25FTGUS is a delivery order under SPE2DB25D2204, an indefinite delivery contract.
Was contract SPE2DB25FTGUS competed?
The extent of competition for SPE2DB25FTGUS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award